Blocking a key receptor may curb immunotherapy-related liver damage. Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
- Ponto de atenção: blocking.
- Ponto de atenção: receptor.
- Ponto de atenção: curb.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/7ec34171-7eb9-450c-9155-331464a45076.png)
:quality(85)/033c7137-e0e6-4534-ade1-84b3955d9d4c.webp)